Bad Blood: Secrets and Lies in a Silicon Valley Startup — Silicon Valley fraud with real patient stakes

Bottom line: This is the business book that actually deserves your time. All eleven hours of it.

Look, I've sat through countless startup post-mortems. I've watched founders crash and burn because they confused confidence with competence. But Elizabeth Holmes? She built a $9 billion house of cards on literal vaporware. And John Carreyrou documented every lie, every intimidation tactic, every board member who should've known better. This isn't just investigative journalism - it's a case study in how Silicon Valley's "fake it till you make it" culture can turn genuinely dangerous.

Here's the thing that got me. My parents ran a dry cleaning business for thirty years. Thirty years of showing up, doing the actual work, delivering what they promised. No pitch decks. No "vision." Just results. Holmes raised hundreds of millions on a blood-testing device that didn't work, while my mom was pressing shirts at 6 AM to make payroll. The audacity of it - and I mean that in the worst possible way - is staggering.

Will Damron's narration is exactly what this story needs. Clean. Precise. Almost clinical. He reads it like a prosecutor laying out evidence, which is basically what Carreyrou did. Some people might want more dramatic flair, but honestly? The facts are dramatic enough. When you're describing a company that ran fake tests on actual patients - tests that could've led to wrong cancer diagnoses or unnecessary treatments - you don't need vocal theatrics. Damron lets the horror speak for itself.

I listened to most of this during my morning runs, and there were moments I literally stopped on the sidewalk. (Jenny asked why my pace was so erratic that week. I told her I was processing corporate fraud. She didn't ask follow-up questions.) The scene where a young employee realizes the machines are basically running samples on modified commercial analyzers while the company claims proprietary technology? I've seen that exact moment of realization in consulting engagements. The "oh no" moment when someone junior figures out the emperor has no clothes.

Now, fair warning - there are a lot of players in this story. Engineers, board members, investors, Walgreens executives, lawyers. Damron does his best, but around hour six I started making mental notes just to keep track. This is where the audiobook format gets tricky. In print, you can flip back. Here, you're kind of trusting Carreyrou to remind you who's who. He mostly does, but if you zone out for five minutes, you might miss a key character reappearing.

What makes this different from your typical business scandal book is the stakes. This isn't Enron playing accounting games with energy futures. This is a healthcare company running unreliable blood tests on real patients in real Walgreens stores. The stakes reminded me of Great Influenza—both show what happens when healthcare decisions get made without proper scientific rigor. Carreyrou documents cases where people got false positives, false negatives, results that could've changed treatment decisions. The section on the lab conditions - and I've seen some sketchy operations in my consulting days - made me genuinely angry.

The board composition alone is a case study in what not to do. Leaders Eat Last talks about what good leadership looks like—this was the exact opposite. Henry Kissinger. George Shultz. Jim Mattis. Zero healthcare expertise. Zero scientific oversight. All prestige, no substance. I've seen this fail at three different companies - maybe not at this scale, but the pattern is identical. Stack your board with impressive names instead of relevant expertise, and nobody asks the hard questions.

At 2.0x speed, this clocked in around six hours for me. Totally manageable. Carreyrou writes tight - there's very little filler here, which is rare for a book this length. Every chapter advances the story or deepens your understanding of how the fraud operated. Finally, a business book that respects your time.

The only thing I wanted more of was the aftermath. The updated afterword covers Holmes's trial, but I would've loved deeper analysis of what this means for healthcare startups going forward. How do we prevent the next Theranos? But that's probably a different book.

Jenny would say I'm being harsh on Holmes. Jenny is right - I have zero sympathy. When you're playing games with people's health to maintain your valuation, you don't get the "visionary founder" defense.

Who should listen: Anyone in venture capital, anyone joining an early-stage startup, anyone who thinks "disruption" is automatically good. Skip it if you want a redemption arc or balanced "both sides" treatment - this is a prosecutor's brief, and rightly so. It's a reminder that the emperor can be naked for years if enough powerful people are invested in the clothes.